Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hanefeld

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
Atherosclerosis|June 1, 1980
Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liverM Hanefeld, C Kemmer, W Leonhardt, et al.
Diabetes Research and Clinical Practice|March 29, 2001
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabeticsE Standl, G Schernthaner, J Rybka, et al.
The American Journal of Cardiology|September 16, 1998
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studiesJ Davignon, M Hanefeld, N Nakaya, et al.
Diabetologia|September 27, 2006
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitusI Raz, M Hanefeld, L Xu, et al.
Atherosclerosis|June 25, 1999
Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individualsM Hanefeld, C Koehler, F Schaper, et al.
Deutsche Medizinische Wochenschrift (1946)|March 21, 2001
[Intima-media thickness in healthy probands without risk factors for arteriosclerosis]T Temelkova-Kurktschiev, S Fischer, C Koehler, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2001
Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and DiabetesM Hanefeld, C Koehler, E Henkel, et al.
Diabetes, Nutrition & Metabolism|June 13, 2002
Impaired glucose tolerance is not associated with lipid intoleranceE Henkel, Th Temelkova-Kurktschiev, C Koehler, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 5, 1999
Impaired fasting glucose is not a risk factor for atherosclerosisM Hanefeld, T Temelkova-Kurktschiev, F Schaper, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 29, 2000
Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?T Temelkova-Kurktschiev, E Henkel, F Schaper, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Atherosclerosis|June 1, 1980
Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liverM Hanefeld, C Kemmer, W Leonhardt, et al.
Diabetes Research and Clinical Practice|March 29, 2001
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabeticsE Standl, G Schernthaner, J Rybka, et al.
The American Journal of Cardiology|September 16, 1998
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studiesJ Davignon, M Hanefeld, N Nakaya, et al.
Diabetologia|September 27, 2006
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitusI Raz, M Hanefeld, L Xu, et al.
Atherosclerosis|June 25, 1999
Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individualsM Hanefeld, C Koehler, F Schaper, et al.
Deutsche Medizinische Wochenschrift (1946)|March 21, 2001
[Intima-media thickness in healthy probands without risk factors for arteriosclerosis]T Temelkova-Kurktschiev, S Fischer, C Koehler, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2001
Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and DiabetesM Hanefeld, C Koehler, E Henkel, et al.
Diabetes, Nutrition & Metabolism|June 13, 2002
Impaired glucose tolerance is not associated with lipid intoleranceE Henkel, Th Temelkova-Kurktschiev, C Koehler, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 5, 1999
Impaired fasting glucose is not a risk factor for atherosclerosisM Hanefeld, T Temelkova-Kurktschiev, F Schaper, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 29, 2000
Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?T Temelkova-Kurktschiev, E Henkel, F Schaper, et al.
Pageof 23